HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoya Masumori Selected Research

Naoya Masumori Research Topics

Disease

67Neoplasms (Cancer)
04/2022 - 02/2002
52Prostatic Neoplasms (Prostate Cancer)
07/2021 - 02/2002
36Renal Cell Carcinoma (Grawitz Tumor)
04/2022 - 01/2002
30Neoplasm Metastasis (Metastasis)
04/2022 - 05/2003
30Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 06/2004
26Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2019 - 06/2002
17Overactive Urinary Bladder (Overactive Bladder)
03/2022 - 01/2010
16Carcinoma (Carcinomatosis)
01/2022 - 05/2003
14Lower Urinary Tract Symptoms
10/2018 - 11/2006
9Disease Progression
04/2022 - 07/2006
8Lymphatic Metastasis
06/2021 - 11/2002
7Interstitial Cystitis (Interstitial Cystitis, Chronic)
11/2021 - 10/2006
7Gender Dysphoria
01/2021 - 05/2009
5Margins of Excision
06/2017 - 01/2008
5Surgical Wound Infection
02/2015 - 08/2007
4Urinary Incontinence
01/2021 - 03/2010
4Acute Kidney Injury (Acute Renal Failure)
05/2020 - 01/2016
4Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2020 - 06/2002
4Testicular Neoplasms (Testicular Cancer)
01/2018 - 06/2006
4Adenocarcinoma
01/2017 - 08/2011
3Edema (Dropsy)
11/2021 - 01/2017
3Hemorrhage
11/2021 - 04/2005
3Cystitis
08/2021 - 01/2017
3Fever (Fevers)
05/2021 - 08/2011
3Urinary Retention
03/2021 - 11/2018
3Bacteremia
05/2020 - 04/2015
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2018 - 06/2006
3Non-Muscle Invasive Bladder Neoplasms
07/2018 - 11/2014
3Insulin Resistance
11/2017 - 04/2007
3Infections
01/2017 - 10/2013
3Febrile Neutropenia
10/2015 - 08/2014
3Anorexia
10/2015 - 06/2011
3Abscess
02/2015 - 07/2007
3Neuroendocrine Carcinoma
04/2013 - 01/2004
3Residual Neoplasm
01/2011 - 02/2006
3Underactive Urinary Bladder
05/2010 - 11/2006

Drug/Important Bio-Agent (IBA)

17Prostate-Specific Antigen (Semenogelase)IBA
04/2021 - 08/2004
15AndrogensIBA
06/2021 - 01/2004
10Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2006
9Hormones (Hormone)IBA
01/2021 - 01/2004
8Sunitinib (Sutent)FDA Link
04/2022 - 06/2013
8Tamsulosin (Flomax)FDA LinkGeneric
11/2018 - 11/2005
6GemcitabineFDA Link
01/2022 - 03/2008
5NivolumabIBA
04/2022 - 05/2020
5Axitinib (AG 013736)IBA
04/2022 - 11/2018
5Radium-223IBA
04/2021 - 02/2018
5Testosterone (Sustanon)FDA Link
01/2019 - 06/2004
5Cholinergic Antagonists (Anticholinergics)IBA
05/2018 - 01/2011
5naftopidilIBA
01/2016 - 11/2005
4N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
03/2022 - 01/2019
4Biomarkers (Surrogate Marker)IBA
10/2021 - 06/2013
4Pharmaceutical PreparationsIBA
08/2021 - 06/2013
4Androgen Receptors (Androgen Receptor)IBA
04/2021 - 01/2004
4SteroidsIBA
02/2021 - 11/2017
4Tyrosine Kinase InhibitorsIBA
11/2020 - 08/2014
4C-Reactive ProteinIBA
10/2019 - 02/2010
4Dutasteride (Avodart)FDA Link
09/2019 - 03/2011
4silodosinFDA Link
10/2018 - 09/2008
4Solifenacin SuccinateFDA Link
10/2016 - 01/2010
4IsoflavonesIBA
09/2016 - 08/2004
4Proteins (Proteins, Gene)FDA Link
01/2015 - 12/2008
3pazopanibFDA Link
04/2022 - 08/2014
3EverolimusFDA Link
04/2022 - 06/2013
3Aldehyde Dehydrogenase 1 FamilyIBA
01/2021 - 01/2013
3Sorafenib (BAY 43-9006)FDA Link
01/2020 - 12/2008
3CytokinesIBA
09/2019 - 06/2013
3propiverineIBA
05/2018 - 01/2011
3Etoposide (VP 16)FDA LinkGeneric
01/2018 - 02/2006
3CreatinineIBA
10/2017 - 04/2007
3Zoledronic Acid (Zometa)FDA Link
02/2017 - 04/2013
3EquolIBA
09/2016 - 01/2013
3GenisteinIBA
09/2016 - 08/2004
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2015 - 02/2006
3Interferon-alpha (Interferon Alfa)IBA
08/2014 - 12/2008
3imidafenacinIBA
10/2013 - 01/2011
3SurvivinIBA
01/2013 - 11/2009
3Androgen Antagonists (Antiandrogens)IBA
03/2011 - 06/2004
3AntigensIBA
12/2009 - 04/2007
3Tumor Viral Antigens (Large T Antigen)IBA
01/2004 - 05/2003

Therapy/Procedure

46Therapeutics
01/2022 - 08/2004
30Cystectomy
01/2022 - 06/2004
26Drug Therapy (Chemotherapy)
01/2022 - 02/2006
17Castration
06/2021 - 06/2004
13Nephrectomy
04/2022 - 01/2002
12Lymph Node Excision (Lymph Node Dissection)
11/2017 - 11/2002
10Prostatectomy (Retropubic Prostatectomy)
06/2017 - 05/2004
8Nephroureterectomy
06/2021 - 08/2007
7Urinary Diversion (Ileal Conduit)
01/2022 - 10/2004
7Radiotherapy
06/2021 - 05/2004
7Neoadjuvant Therapy
10/2019 - 08/2008
6Aftercare (After-Treatment)
01/2021 - 10/2006
5Operative Surgical Procedures
05/2020 - 09/2009
5Molecular Targeted Therapy
01/2020 - 06/2013
5Transurethral Resection of Prostate (TURP)
05/2010 - 02/2002
4Immunotherapy
04/2022 - 11/2008
4Intravesical Administration
01/2021 - 12/2006
4Sex Reassignment Surgery
01/2016 - 05/2010
3Urinary Catheters
03/2021 - 11/2010
3Conservative Treatment
05/2020 - 08/2011
3Renal Dialysis (Hemodialysis)
05/2020 - 03/2008